Dr. Ron Chandler is a 2013 Ann Schreiber Mentored Investigator Award recipient. In this interview with OCRF’s Sarah DeFeo, Dr. Chandler discusses his research and what it means to receive a grant from OCRF. Sarah DeFeo: Tell us about yourself. Ron Chandler: I am the first Ph.D. scientist in my family, although my Grandpa and Dad … Continued
A new study released today by MD Anderson Cancer Center in Texas shows that a family of microRNAs (miR-200) blocks cancer progression by cutting off the tumor’s ability to build new blood vessels. These findings highlight the potential of biomarkers for identifying patients who might benefit from treatment. Dr. Anil Sood says “safety studies will need … Continued
Washington, DC—A new report released by the Ovarian Cancer National Alliance summarizes the experiences of 1,014 women diagnosed with ovarian cancer. Based on a survey conducted by the Alliance in partnership with Inspire, the report details how women were diagnosed and whether their treatment followed national guidelines for ovarian cancer. The survey was inspired by … Continued
Dr. Maria Barbolina is a 2013 Liz Tilberis Early Career Award grant recipient. In this interview with OCRF’s Sarah DeFeo, Dr. Barolina discusses her research and what it means to receive a grant from OCRF. Sarah DeFeo: Tell us a little about yourself. Maria Barbolina: I live in Chicago now, but my life started on the … Continued
An ovarian cancer survivor in Australia, Vali, is 26-weeks pregnant after being told she was infertile due to ovarian cancer treatments. “The sample of Vali’s ovarian tissue was taken from her cancer-free ovary through keyhole surgery and frozen. Seven years later, the tissue was grafted onto the left and right sides of the front wall … Continued
A new OCRF-funded study from researchers at the University of Michigan Comprehensive Cancer Center found that a subset of immune cells, called myeloid derived suppressor cells, do more harm than good by providing a niche where the cancer stem cells survive. The research is published in the journal Immunity. Cancer stem cells are thought to be … Continued
“This month, we extend a hand to all women battling ovarian cancer. We pledge our support to them, to their families, and to the goal of defeating this disease.”-President Barack Obama Read full proclamation here.
Researchers in the UK have identified a gene in mice that, if faulty, may increase the chance of developing a rare type of ovarian cancer. The findings were published in the journal Nature. The gene, known as Helq, helps repair damage to DNA that happens when it is copied as cells multiply. If the gene is missing or … Continued
An index created at The University of Texas MD Anderson Cancer Center in Houston, based on protein biomarkers was able to discriminate between women at high risk and low risk for ovarian cancer recurrence, in a recent analysis. Such information can be used to help improve the treatment and, eventually, the prognosis of patients with ovarian … Continued
The Washington Post explores new options for young women going through cancer treatment who want to know about their options for having children after treatment. The article looks at emerging methods and ways to approach the conversation with your doctor. Read the article here.
Building on previously presented work, researchers at M.D. Anderson Cancer Center in Houston have published new findings that show that evaluating the change of CA-125 over time shows promise as a screening tool for early-stage ovarian cancer. OCRF grantees Karen Lu, MD and Robert Bast, MD were first and senior author on the paper, which … Continued
The Petersen family was inspired to educate the world about small cell ovarian cancer while their daughter and sister Stephanie was undergoing treatment for the disease. “The first thing they said to us was, ‘Don’t look on the internet—you won’t find anything about small cell ovarian cancer,’ ” recalls Maren Petersen. Discouraged by the lack … Continued
Get email updates about research news, action alerts, and ways to join the fight.
